BioLargo Inc (OTCQB:BLGO) said it has taken the next step to commercialize the new wastewater treatment technology called the "minimal liquid discharge" system, which it designed and manufactured for Garratt-Callahan, a century-old national water treatment company.
At this stage, the company said its engineers will process contaminated water with a full-scale prototype of the new technology to verify its treatment efficacy and durability. Once this stage is completed successfully, it said sales can begin to Garratt-Callahan customers.
"We are excited to be working with Garratt-Callahan to launch this product because of their pedigree of innovation and integrity in the water industry,” Randall Moore, president of BioLargo Engineering, Science & Technologies, said in a statement.
“Their focus on developing technologies that reduce freshwater usage aligns with our values of focusing on sustainable solutions above all else," added Moore.
The new wastewater treatment system is based on Garratt-Callahan's minimal liquid discharge (MLD) technology, which reduces the volume of wastewater discharged from industrial facilities, saving customers disposal fees while reducing strain on sewage infrastructure and the environment.
BioLargo said engineers start by treating simulated industrial wastewater to optimize the technology's performance, then finish by treating actual industrial wastewater provided by Garratt-Callahan customers.
"This project highlights our capabilities to serve customers as an innovator and solutions provider in wastewater treatment,” said BioLargo’s director of strategic marketing and business development Tonya Chandler.
“We helped scale the design of the MLD system, we manufactured it, and now we're testing it in our in-house water lab to validate its performance before it ships to customers.”
BioLargo invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water, and wastewater treatment, industrial odor, and VOC control, air quality control, and infection control.
Contact the author at stephen.gunnion@proactiveinvestors.com